Releasing the brake on the immune system: The PD-1 strategy for hematologic malignancies

Locke Johnson Bryan, Leo I. Gordon

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Incorporation of PD-1 blockade into the treatment algorithms for hematologic malignancies is currently being pursued in multiple active clinical trials. Here we review the data on anti–PD-1 monoclonal antibodies to date and discuss ongoing and future clinical trials.

Original languageEnglish (US)
JournalONCOLOGY (United States)
Volume29
Issue number6
StatePublished - Jun 15 2015
Externally publishedYes

Fingerprint

Hematologic Neoplasms
Immune System
Clinical Trials
Monoclonal Antibodies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Releasing the brake on the immune system : The PD-1 strategy for hematologic malignancies. / Bryan, Locke Johnson; Gordon, Leo I.

In: ONCOLOGY (United States), Vol. 29, No. 6, 15.06.2015.

Research output: Contribution to journalArticle

@article{9bf3b52bf9344f09a5b6298ec1032dc3,
title = "Releasing the brake on the immune system: The PD-1 strategy for hematologic malignancies",
abstract = "Incorporation of PD-1 blockade into the treatment algorithms for hematologic malignancies is currently being pursued in multiple active clinical trials. Here we review the data on anti–PD-1 monoclonal antibodies to date and discuss ongoing and future clinical trials.",
author = "Bryan, {Locke Johnson} and Gordon, {Leo I.}",
year = "2015",
month = "6",
day = "15",
language = "English (US)",
volume = "29",
journal = "ONCOLOGY (United States)",
issn = "0890-9091",
publisher = "UBM Medica Healthcare Publications",
number = "6",

}

TY - JOUR

T1 - Releasing the brake on the immune system

T2 - The PD-1 strategy for hematologic malignancies

AU - Bryan, Locke Johnson

AU - Gordon, Leo I.

PY - 2015/6/15

Y1 - 2015/6/15

N2 - Incorporation of PD-1 blockade into the treatment algorithms for hematologic malignancies is currently being pursued in multiple active clinical trials. Here we review the data on anti–PD-1 monoclonal antibodies to date and discuss ongoing and future clinical trials.

AB - Incorporation of PD-1 blockade into the treatment algorithms for hematologic malignancies is currently being pursued in multiple active clinical trials. Here we review the data on anti–PD-1 monoclonal antibodies to date and discuss ongoing and future clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=84935022408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84935022408&partnerID=8YFLogxK

M3 - Article

C2 - 26091677

AN - SCOPUS:84935022408

VL - 29

JO - ONCOLOGY (United States)

JF - ONCOLOGY (United States)

SN - 0890-9091

IS - 6

ER -